ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,397Medicare Part D Prescriptions Filled, Including Refills

Rank: 131 out of 946

$689K Total Retail Price of All Prescriptions

Rank: 96 out of 946

672 Patients Receiving at Least One Drug in Part D
84% Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Arizona
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 672 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 672 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 431 385 107 1 1
AMLODIPINE BESYLATE 371 339 99 2 4
SIMVASTATIN 368 339 93 3 3
HYDROCODONE-ACETAMINOPHEN 334 242 75 S3 4 10
LISINOPRIL 327 303 83 5 2
LOSARTAN POTASSIUM 273 251 67 6 13
ATORVASTATIN CALCIUM 261 239 73 7 7
PRAVASTATIN SODIUM 229 208 52 8 16
METFORMIN HCL 213 174 54 9 6
METOPROLOL TARTRATE 207 196 47 10 8
OMEPRAZOLE 191 186* 54 11 5
HYDROCHLOROTHIAZIDE 185 166 56 12 14
METOPROLOL SUCCINATE 175 138 41 13 18
BENAZEPRIL HCL 173 143 50 14 91
LOVASTATIN 147 131 36 15 22
FUROSEMIDE 138 121 35 16 9
GABAPENTIN 126 76 38 17 12
FLUTICASONE PROPIONATE 121 116* 58 18 23
LORAZEPAM 114 81 21 B 19 31
ALENDRONATE SODIUM 111 86 26 20 28
TAMSULOSIN HCL 110 105* 25 21 27
SERTRALINE HCL 106 94 24 22 26
WARFARIN SODIUM 104 86 18 23 11
ZOLPIDEM TARTRATE 102 78 28 24 20
ALLOPURINOL 97 92* 26 25 35
FINASTERIDE 91 91 20 26 60
TRAZODONE HCL 90 71 22 27 34
POTASSIUM CHLORIDE 88 77 24 28 17
FLUOXETINE HCL 88 72 18 28 51
RANITIDINE HCL 85 55 18 30 32
ATENOLOL 84 79* 27 31 15
ALPRAZOLAM 81 51 24 B 32 29
CLONAZEPAM 79 53 23 B 33 58
VALSARTAN-HYDROCHLOROTHIAZIDE 76 76 14 34 125
CARVEDILOL 76 71* 22 34 37
OXYCODONE HCL 73 40 16 S2 36 41
AMLODIPINE BESYLATE-BENAZEPRIL 72 67* 19 37 157
CYMBALTA 67 24 15 38 54
BACLOFEN 66 29 18 39 92
VYTORIN 66 61* 14 39 108
PAROXETINE HCL 62 41 21 41 55
DONEPEZIL HCL 61 <11 <11 42 33
SPIRIVA 61 48 17 42 75
PANTOPRAZOLE SODIUM 60 55* 14 44 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 53* 11 45 47
ESCITALOPRAM OXALATE 57 57 14 46 61
PREDNISONE 56 51* 15 47 45
CRESTOR 55 55 14 48 30
CLOPIDOGREL 54 49* 18 49 19
CELEBREX 52 <11 <11 50 82
DILTIAZEM ER 50 39 11 51 140
DOXAZOSIN MESYLATE 50 <11 <11 51 67
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.